Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Operating Expenses | 1,110 | 1,547 | 1,909 | 1,174 | 3,460 |
| Operating Income | -1,110 | -1,547 | -1,909 | -1,174 | -3,460 |
| Interest Expense | 677 | 798 | 1,256 | 471 | 1,820 |
| Other Income | 154 | 668 | -596 | 544 | 2,410 |
| Pre-tax Income | -1,633 | -1,677 | -3,761 | -1,102 | -2,870 |
| Income Tax | 1 | -306 | N/A | N/A | N/A |
| Net Income Continuous | -1,634 | -1,371 | -3,761 | -1,102 | -2,857 |
| Net Income | $-1,634 | $-1,371 | $-3,761 | $-1,102 | $-2,857 |
| EPS Basic Total Ops | -0.37 | -0.38 | -1.13 | -0.36 | N/A |
| EPS Basic Continuous Ops | -0.38 | -0.38 | -1.13 | -0.36 | -3.77 |
| EPS Diluted Total Ops | -0.37 | -0.38 | -1.13 | -0.36 | N/A |
| EPS Diluted Continuous Ops | -0.38 | -0.38 | -1.13 | -0.36 | -3.77 |
| EBITDA(a) | $-1,109 | $-1,547 | $-1,909 | $-1,174 | $-3,460 |